The response of atrial pressure, venous pressure, pulse and respiratory rates to intravenous hexamethonium in 38 selected patients was studied. The drug seemed more effective where vascular tone was greater. Increased venous tone was indicated in congestive heart failure. The possible useful role of intravenous hexamethonium as an adjunct in the treatment of congestive heart failure was concluded from the objective and subjective observations made.
T HE immediate effects of hexamethonium on venous pressure and congestive heart failure have been reported previously.' 2 There was a variable decline in venous pressure associated with some relief of dyspnea. Since the drug seemed to have possible therapeutic value in congestive heart failure, knowledge of the duration of action as well as the time course relationship of changes in venous pressure to arterial pressure, pulse rate and respiratory rate may be important. Since previous observations have been concerned principally with hypertensive heart disease with congestive heart failure, data on the response of patients with normal arterial pressure and elevated venous pressure are lacking. METHOD Thirty-eight patients grouped into four categories of study were hospitalized at the Charity Hospital and had been at bed rest for varying lengths of time before these observations were made. Ten of the subjects who were convalescing from various disease states were normotensive without congestive heart failure (table 1), nine were normotensive patients with congestive heart failure (table 2), 10 were hypertensive patients without congestive heart failure (table 3), and nine had hypertensive heart disease and congestive heart failure (table 4). In addition to bed rest, all of the patients with congestive heart failure were receiving therapy includ- ing digitalis, salt restriction, diuretics and, in some cases, nasal oxygen at the time of the study. Venous pressure was measured in the median basilic vein by means of a saline manometer and all values were corrected to the phlebostatic level.3 All observations included measurements of venous pressure, arterial pressure, pulse and respiratory rates as well as the usual clinical observations including attention to gallop rhythm, pulsus alternans, basal rales and dyspnea. Several consecutive observations were made to establish a control or basal level and were repeated as often as possible during intravenous injection of *hexamethonium and at hourly intervals thereafter until the venous pressure returned to the control level. Prior to, immediately following the injection of hexamethonium, and at the end of the observation, the magnitude of the hepatojugular reflux was recorded after pressure had been exerted on the right upper quadrant of the abdomen for one minute.
The rate of injection as well as the dosage administered was recorded. There was considerable variation in the dosage and the rate of, administration, the latter being intermittent (tables 1-4, figs. 1-4).
RESULTS
The results are summarized for all four groups separately in tables 1 through 4 In Normotensive Patients with Congestive Heart Failure. The response of four normotensive patients with congestive heart failure followed the pattern summarized by figure 2a and table 2, subject 12. There was a more marked and rapid fall in venous pressure than in arterial pressure with the pulse and respiratory rates remaining unchanged. With the fall in venous pressure, the hepatojugular reflux was absent but returned when the venous pressure approached control level again. Both arterial pressure and venous pressure returned to the control levels within two hours. The other type of response summarized by figure 2b and table 2, subject 16, was observed in 4 patients. Here again, venous pressure began to fall before arterial pressure. The magnitude of the hepatojugular reflux was not diminished by the injection, and at the end of a 13-hour period arterial pressure had returned to the control level while venous pressure had failed to do so.
The average dose of hexamethonium was 10.1 mg. injected over a period of 7.7 minutes. Following intravenous administration of hexamethonium, there was a mean fall in venous pressure of 79 mm. H20 and a decrease in the magnitude of the hepatojugular reflux of 17 mm. H20. http://circ.ahajournals.org/ 22.8 mg. administered over a period of 15.3 minutes. Venous pressure declined an average of 14 mm. H20 and arterial pressure declined an average of 47/19 mm. Hg. There was a slight increase in pulse rate of 6.6 per minute without a change in respiratory rate.
In Patients with Hypertensive Heart Disease with Congestive Heart Failure. Four of the nine patients with hypertensive heart disease and congestive heart failure responded with marked simultaneous fall in venous pressure, arterial pressure and pulse rate, with little change in respiratory rate ( fig. 4a and table 4 , subject 35). The hepatojugular reflux was absent following hexamethonium. At the end of a threehour period, the venous pressure and the magnitude of the hepatojugular reflux had returned to the control level, but the arterial pressure and pulse rate remained at a lower level. The other type of response elicited in the other five patients is summarized by figure 4b and (mg) o in the magnitude of the hepatojugular reflux or pulse and respiratory rates. Venous pressure required over eight hours to return to control levels while the blood pressure had not returned to control levels in 20 hours.
The average dose of hexamethonium was 21 mg., injected over a period of 11 minutes. The decline in venous pressure averaged 85 mm. H20 and the hepatojugular reflux decreased 18 mm. H20. The average time for the venous pressure to return to the control level was 3.5 hours. Arterial pressure declined an average of 44/26 mm. Hg and pulse rate was reduced 13.5 beats per minute. The respiratory rate changed insignificantly.
The Effects of Intravenous Administration
of Hexamethonium on Dyspnea, Basal Rales, Pulsus Alternans, and Gallop Rhythm. Two of the nine normotensive subjects with congestive heart failure with a protodiastolic gallop rhythm had no change in the rhythm following injection of the drug. All nine subjects were dyspneic prior to injection, and all experienced considerable improvement in this symptom. stopped regardless of the dose administered up to that point. The maximum dose administered, regardless of the degree of response, was 25 mg. Thus, the dosage varied considerably and in a relatively unstandardized manner. It is also apparent that doses larger than 25 mg. might have increased the magnitude of the response or might have caused a response when none was observed with the maximum dose of 25 mg. used in these studies. It is interesting to note that the average dose of hexamethonium was about the same for all the subjects without failure and for the hypertensive group with failure. The average dose required to elicit a response in the patients with congestive heart failure and normal arterial pressure was approximately half that of the other groups. Only one patient in this group received as much as 25 mg. and one patient had a marked response to as little as 3.75 mg. The reason for this "increased sensitivity" in the normotensive subjects with congestive heart failure is not apparent. This type of reaction had been observed by others using hexamethonium and other vasodilating agents.", 4, 5 It is generally agreed that drugs and procedures which influence peripheral blood vessels exert the same influence on both the arteries and the veins.6 However, it was possible to select the patients in these experiments so that the effects of the drug could be observed when both arterial and venous pressure (tone) were normal, when the venous pressure was high and arterial pressure normal, when arterial pressure was high and venous pressure normal and when the pressures were elevated in both the arterial and venous sides of the circulation. By such a selection, it was possible to observe the effects of hexamethonium on the reactions of arteries and veins when either or both showed a disproportional increase in tone. In subjects who had normal arterial and venous pressures-therefore normal tone-(group 1), gaiiglionic blockade was without much effect. However, the degree and duration of its effect on the veins and arteries differed in two instances. In the normotensive subjects who had congestive heart failure with venous hypertension (group 2) the decline in arterial pressure was greater than in the normotensive patients without failure. The decline in venous pressure in the subjects of group 2 was considerably greater than that in patients of group 1 in both absolute values and in percentile levels. The decline in venous pressure in the subjects of group 2 was greater than the decline in arterial pressure which declined only slightly. Thus, although the arterial pressure was within the established limits of normal in these subjects with congestive heart failure, there was evidence of an increase in arteriolar and arterial tone when compared with the subject with normal arterial pressure but without failure.
In hypertensive subjects without heart failure (group 3) the decline in arterial pressure was comparable to the change in pressure in the hypertensive patients with congestive heart failure in both absolute values and percentile levels. However, in subjects of group 3 the decline in venous pressure was much smaller than that in those of group 4 with venous hypertension. It was also observed that the subjects in whom venous pressure was normal, there was relatively little change in venous pressure following hexamethonium, although the arterial pressure declined (group 3).
In all subjects in whom there was an increase in venous pressure, the effect on venous pressure was greater regardless of the state of the associated arterial pressure. It was, therefore, demonstrated that the effect upon the veins was greater when the venous tone was abnormally increased. Furthermore, hexamethonium resulted in different degrees of reaction in the arterial and venous sides of the circulation. Not only did the degree of reaction differ, but there was a variation in the duration of the effect on the venous and arterial pressures as evidenced by the fact that the return to the control level of either was independent of the other. The actual time required for the venous pressure to return to the base-line level varied considerably; in some instances return to this level was not accomplished during the period of observation.
Additional evidence of the action of hexamethonium on venous tone was available from studies on the hepatojugular reflux. With normal venous tone, venous pressure in the arm responded to right upper quadrant pressure either by no change in pressure or a decrease, whereas when the venous pressure was elevated, the response consisted of a further increase in pressure.7' 8 SUMMARY These observations showed that hexamethonium lowers venous pressure in congestive heart failure and that the effect on the peripheral arteries, arterioles and veins was greatest where tone was highest. The duration of the effect on venous pressure varied from 1 to 13 hours or longer. These observations also indicate the possible value and role of hexamethonium in the management of congestive heart failure. 
